Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-08-01

Clinical Trial Update: Early Administration of Fibrinogen in Polytraumatized Patients With Hypofibrinogenemia: a Randomized Feasibility Trial [Phase 4]

View source ↗

Summary

A Phase 4 randomized feasibility trial investigates early administration of fibrinogen in polytraumatized patients with hypofibrinogenemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fibrinogen (fibrinogen)

Snippet

Sponsor: University of Sao Paulo General Hospital | Conditions: Trauma, Bleeding Disorder | Phase 4 | Status: COMPLETED